Search

everythinglearnresearchcommunity

for

Search:↓

Early-onset male baldness is not linked to insulin resistance, but is significantly associated with metabolic syndrome.

Early-onset male baldness is significantly linked to metabolic syndrome, suggesting those with early baldness should consider preventive treatment to reduce risk.

Early balding in men is linked to metabolic syndrome, so screening is important for prevention.

People with androgenetic alopecia, both men and women, are more likely to develop heart diseases in the future.

There's no clear link between female pattern hair loss, insulin resistance, and metabolic syndrome.

People with early-onset hair loss have higher risk of heart issues, so early screening is important.

Men with early hair loss and hormonal changes like PCOS could be the male equivalent of PCOS, not linked to metabolic syndrome.

Men with certain patterns of hair loss, especially the U pattern, are more likely to develop insulin resistance.

Women with the NIH type of PCOS have more obesity and higher risk of diabetes and heart disease than those with other types of PCOS.

The study suggests that being overweight or obese, not PCOS itself, is strongly linked to insulin resistance.

Vertical sleeve gastrectomy improved metabolism, behavior, and reproduction in obese rats with PCOS.

Changing the diagnosis criteria for PCOS might miss women at risk for related health issues.

Obese Hispanic women with PCOS are at higher risk for metabolic problems than non-Hispanic white women.

Chromium supplements don't help with weight loss or improve hormone and metabolism issues in people with polycystic ovary syndrome.

Lipid Accumulation Product and Free Androgens Index are effective for assessing fatty liver disease risk in women with Polycystic Ovary Syndrome.

Managing metabolic syndrome needs both lifestyle changes and medical treatments.

ARL15 is important for fat cell development and the release of the hormone adiponectin.

The supplement with Myo-inositol and D-chiro-inositol improves metabolic symptoms in PCOS, especially when combined with metformin.

Early life factors, including a mother's health and environment, can affect the chances of developing polycystic ovary syndrome later in life.

High fasting insulin levels in women with PCOS are linked to a higher risk of heart and metabolic problems.

Metformin effectively improves metabolic symptoms in women with PCOS, while alfacalcidiol does not have a significant impact.

PCOS causes infertility mainly due to hormonal imbalances, insulin resistance, and chronic inflammation.

Curcumin improved some metabolic factors in women with PCOS but did not affect cholesterol, insulin, or testosterone levels.

Hypothyroidism may worsen metabolic problems like insulin resistance and obesity in women with PCOS.

Children with metabolic syndrome often have skin problems like dark patches, skin tags, stretch marks, infections, acne, and psoriasis, which are linked to obesity and insulin resistance.

Metformin has limited effectiveness for improving PCOS symptoms and lacks clear benefits, needing more research to confirm its efficacy.

Obese women with PCOS are more likely to have fatty liver disease.

Women with PCOS in North China often have hirsutism and acne, with hirsutism linked to metabolic issues.

Patients with oral lichen planus or oral lichenoid reactions had worse cholesterol levels and a higher risk of obesity compared to healthy individuals.

Overweight women with PCOS have higher levels of certain hormones that could indicate a higher risk of heart and metabolic problems.